Is radiofrequency ablation justified for liver metastatic VIPoma patient undergoing Whipple procedur

来源 :中华医学杂志(英文版) | 被引量 : 0次 | 上传用户:seedvs18606
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Vasoactive intestinal polypeptide secreting tumors (VIPoma) are one kind of rare endocrine tumor which is mostly located in the pancreas.The annual incidence was estimated to be about 1 per 10 000 000 individuals in general population.1 The VIPoma is usually associated with Verner-Morrison syndrome following tremendous over-secretion of vasoactive intestinal polypeptide (VIP), which consisted of water diarrhea,hypokalemia and achlorhydria.This syndrome has been termed pancreatic cholera, watery diarrhea syndrome.
其他文献
Background Classic mastoidectomy and modified mastoidectomy are traditional surgical procedures for middle ear cholesteatoma with goals of eradicating diseases,
Background The main risk factor for chronic obstructive pulmonary disease (COPD) is cigarette smoking. However, only 10%-20% of chronic heavy smokers develop sy
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary thrombo-embolism (PTE), carries significant mortality and morbidity. As a resul
Three-dimensional crack closure correction methods are investigated in this paper.The fatigue crack growth tests of surface cracks in 14MnNbq steel for bridge p
AIM: To report the incidence of non-small-bowel bleeding pathologies encountered during double-balloon enteroscopy (DBE) procedures and to analyse their signifi
PTPMEG1 is an intracellular protein tyrosine phosphatase(PTP), which contains FERM and PDZ domains. This study focuses our attention on the expression, purifica
Background Subcutaneous specific immunotherapy has been demonstrated to be capable of inducing T-cell regulatory response.Interleukin-10 (IL-10) plays a crucial
Superior mesenteric artery syndrome (SMAS) is a rare etiology of duodenal obstruction resulting from the compression of the third part of the duodenum between t
In February 2005, Gefitinib (Iressa), a small-molecular epidermal growth factor receptor and tyrosine kinase inhibitor, was approved in China as an anticancer a